NL157010B - Werkwijze voor het bereiden van anti-hypertensief werkzame esters van alfa-methyl-3,4-dihydroxyfenylalanine en acylderivaten daarvan; werkwijze ter bereiding van farmaceutische preparaten; alsmede de door toepassing daarvan verkregen gevormde voortbrengselen. - Google Patents

Werkwijze voor het bereiden van anti-hypertensief werkzame esters van alfa-methyl-3,4-dihydroxyfenylalanine en acylderivaten daarvan; werkwijze ter bereiding van farmaceutische preparaten; alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.

Info

Publication number
NL157010B
NL157010B NL7412030.A NL7412030A NL157010B NL 157010 B NL157010 B NL 157010B NL 7412030 A NL7412030 A NL 7412030A NL 157010 B NL157010 B NL 157010B
Authority
NL
Netherlands
Prior art keywords
preparing
dihydroxyphenylalanine
alpha
methyl
well
Prior art date
Application number
NL7412030.A
Other languages
English (en)
Dutch (nl)
Other versions
NL7412030A (nl
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NL7412030A publication Critical patent/NL7412030A/xx
Publication of NL157010B publication Critical patent/NL157010B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C07D207/452—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NL7412030.A 1973-09-25 1974-09-10 Werkwijze voor het bereiden van anti-hypertensief werkzame esters van alfa-methyl-3,4-dihydroxyfenylalanine en acylderivaten daarvan; werkwijze ter bereiding van farmaceutische preparaten; alsmede de door toepassing daarvan verkregen gevormde voortbrengselen. NL157010B (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40060973A 1973-09-25 1973-09-25
US05/482,102 US3983138A (en) 1973-09-25 1974-06-25 Amino acid esters
AU30912/77A AU516398B2 (en) 1973-09-25 1977-11-23 Esters of methyl-3, 4-dihydroxyphenyl alanine

Publications (2)

Publication Number Publication Date
NL7412030A NL7412030A (nl) 1975-03-27
NL157010B true NL157010B (nl) 1978-06-15

Family

ID=27153356

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7412030.A NL157010B (nl) 1973-09-25 1974-09-10 Werkwijze voor het bereiden van anti-hypertensief werkzame esters van alfa-methyl-3,4-dihydroxyfenylalanine en acylderivaten daarvan; werkwijze ter bereiding van farmaceutische preparaten; alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.

Country Status (13)

Country Link
US (1) US3983138A (fr)
JP (1) JPS5062944A (fr)
AT (1) AT343639B (fr)
AU (1) AU516398B2 (fr)
BE (1) BE820253A (fr)
CA (1) CA1057767A (fr)
CH (1) CH606027A5 (fr)
DE (1) DE2445584C3 (fr)
FR (1) FR2244488B1 (fr)
GB (1) GB1447599A (fr)
LU (1) LU70966A1 (fr)
NL (1) NL157010B (fr)
OA (1) OA04785A (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198413A (en) * 1973-09-25 1980-04-15 Merck & Co., Inc. Amino acid esters
DK229876A (da) * 1975-06-11 1976-12-12 Merck & Co Inc Fremgangsmade til fremstilling af estere af alfa-methyl-3,4-dihydroxyphenylalanin
FR2365341A1 (fr) * 1976-09-28 1978-04-21 Synthelabo Derives de l'acide l-(phenyl-3 amino-2 propionyloxy)-2 acetique
US4120971A (en) * 1977-03-01 1978-10-17 Merck & Co., Inc. Novel N-carboxy-alpha-amino acid anhydrides
GB1583602A (en) * 1977-05-26 1981-01-28 Sterwin Ag N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
US4401676A (en) * 1977-06-01 1983-08-30 Merck & Co., Inc. Novel α-amino acids
US4271187A (en) * 1978-06-05 1981-06-02 Merck & Co., Inc. Substituted phenyl alanine antihypertensive agents
IL57609A (en) * 1979-06-21 1983-05-15 Yeda Res & Dev Pharmaceutical compositions for the treatment of sickle cell disease comprising p-nitrobenzyl esters or amides of aromatic or hydrophobic aminoacids
US4404392A (en) * 1981-11-16 1983-09-13 Merck & Co., Inc. Resolution of α-pivaloyloxyethyl-(S)-3-(3,4-dihydroxyphenyl)-2-methylalantinate into its α and β isomers
US4360533A (en) * 1981-12-14 1982-11-23 Merck & Co., Inc. Glyceryl ester of 1-methyl-2-(3,4-dihydroxyphenyl)alanine
US4440942A (en) * 1982-03-01 1984-04-03 Merck & Co., Inc. Crystalline diastereomeric L-alpha-methyldopa POE ester and process for its preparation
US4670578A (en) * 1983-08-29 1987-06-02 Merck & Co., Inc. Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
PT79107B (en) * 1983-08-29 1986-11-14 Merck & Co Inc Process for preparing crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
US4914222A (en) * 1983-08-29 1990-04-03 Merck & Co., Inc. Crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
JPH02138A (ja) * 1987-09-18 1990-01-05 Banyu Pharmaceut Co Ltd Ｌ‐ドーパ誘導体
JP4781352B2 (ja) 2004-06-04 2011-09-28 ゼノポート，インコーポレーテッド レボドパプロドラッグおよびその組成物ならびにその使用
ES2391575T3 (es) 2005-12-05 2012-11-27 Xenoport, Inc. Mesilato de profármaco de Levodopa, sus composiciones y sus usos
CA2673336A1 (fr) 2006-12-21 2008-06-26 Xenoport, Inc. Promedicaments diesters dimethyle substitues a base de levodopa et procedes d'utilisation
WO2008079387A1 (fr) 2006-12-21 2008-07-03 Xenoport, Inc. Promédicaments de diester de lévopoda protégés par catechol, compositions et méthodes d'utilisation
JP2012505885A (ja) 2008-10-20 2012-03-08 ゼノポート，インコーポレーテッド レボドパエステルプロドラッグを合成する方法
US8399513B2 (en) 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
CA3029961C (fr) * 2009-10-11 2021-06-22 Rutgers, The State Of University Of New Jersey Polymeres biocompatibles pour dispositifs medicaux
AU2010315892B2 (en) 2009-11-09 2014-09-18 Xenoport, Inc. Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
CN103694127B (zh) * 2013-12-30 2015-04-01 上海交通大学 链霉菌属菌种所产的化合物及该化合物的制备方法和应用
CN113176369B (zh) * 2021-04-09 2022-05-31 浙江省海洋生态环境监测中心 一种海洋贝类产品中有机锡的测定方法

Also Published As

Publication number Publication date
LU70966A1 (fr) 1975-06-16
ATA767874A (de) 1977-10-15
US3983138A (en) 1976-09-28
BE820253A (fr) 1975-03-24
DE2445584C3 (de) 1979-05-10
CH606027A5 (fr) 1978-10-13
AT343639B (de) 1978-06-12
AU3091277A (en) 1978-05-04
DE2445584B2 (de) 1978-08-31
GB1447599A (en) 1976-08-25
AU7336674A (en) 1976-03-25
AU516398B2 (en) 1981-06-04
DE2445584A1 (de) 1975-03-27
NL7412030A (nl) 1975-03-27
CA1057767A (fr) 1979-07-03
OA04785A (fr) 1980-08-31
FR2244488A1 (fr) 1975-04-18
JPS5062944A (fr) 1975-05-29
FR2244488B1 (fr) 1978-06-30

Similar Documents

Publication Publication Date Title
NL157010B (nl) Werkwijze voor het bereiden van anti-hypertensief werkzame esters van alfa-methyl-3,4-dihydroxyfenylalanine en acylderivaten daarvan; werkwijze ter bereiding van farmaceutische preparaten; alsmede de door toepassing daarvan verkregen gevormde voortbrengselen.
NL7413848A (nl) Werkwijze voor de bereiding van farmacologisch werkzame 1,2-benzisoxazoolderivaten en gevormd farmaceutisch preparaat, dat een dezer stoffen
NL184682C (nl) Werkwijze voor de bereiding van piperazine-derivaten met anti-histamine-werking en werkwijze voor de bereiding van farmaceutische preparaten die ze bevatten.
NL140526B (nl) Werkwijze voor de bereiding van farmacologisch werkzame dibenzothiazepinen, werkwijze voor de bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL7411917A (nl) Werkwijze voor de bereiding van dibenzothiepine- derivaten.
NL7409919A (nl) Werkwijze voor de bereiding van dibenzoxepine derivaten.
NL179287C (nl) Werkwijze voor het bereiden van steroiden van de pregnaanreeks, werkwijze ter bereiding van farmaceutische preparaten en gevormd geneesmiddel.
NL179135C (nl) Werkwijze voor de bereiding van acylbenzoxazolinonderivaten.
NL161434C (nl) Werkwijze voor de bereiding van farmaceutische prepara- ten met alfa-sympathicolytische werking, gevormde pre- paraten en werkwijze voor de bereiding van aminoalkyl- tetrahydro 1-ketonaftaleenderivaten.
NL7501914A (nl) Werkwijze voor het bereiden van cefalosporinen, alsmede de toepassing daarvan als farmaceutische preparaten.
NL7416804A (nl) Werkwijze voor het bereiden van prostaglandinen; werkwijze ter bereiding van farmaceutische prepa- raten alsmede de door toepassing daarvan ver- vaardigde voorwerpen.
NL7409832A (nl) Werkwijze voor de bereiding van farmaceu- tische samenstellingen.
NL7415250A (nl) Werkwijze voor de bereiding van ergopeptine- derivaten.
NL7500224A (nl) Werkwijze voor het bereiden van prostaglandine- oga; werkwijze ter bereiding van farmaceu- e preparaten, alsmede de door toepassing an vervaardigde voorwerpen.
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
NL147131B (nl) Werkwijze voor het bereiden van farmacologisch werkzame stilbeenderivaten; werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.
NL185841C (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van voor toepassing daarbij geschikte 5-mercaptopyridoxinederivaten.
NL7414466A (nl) Werkwijze voor de bereiding van 2-oxo-1-pyridi- nylpeniciline en cefalosporinederivaten.
NL7410604A (nl) Werkwijze voor de bereiding van propanolamine- derivaten.
NL7409735A (nl) Werkwijze voor de bereiding van gesubstitueerde isothiazolylureumderivaten.
NL7417010A (nl) Werkwijze voor het bereiden van penicillinen, werkwijze ter bereiding van antibiotisch werk- zame preparaten, alsmede de door de toepassing daarvan verkregen gevormde voortbrengselen.
NL7411092A (nl) Werkwijze voor de bereiding van aminopyrrool- derivaten.
NL7416454A (nl) Werkwijze voor het bereiden van benzopyranderi- ; werkwijze ter bereiding van farmaceutische raten en de aldus verkregen gevormde voort- selen.
NL7416112A (nl) Werkwijze voor de bereiding en toepassing van pyridine derivaten.
NL7409731A (nl) Werkwijze voor de bereiding van gesubstitueerde nitrobenzofenonderivaten.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: MERCK